| Tag | Content |
|---|
EnhancerAtlas ID | HS029-08598 |
Organism | Homo sapiens |
Tissue/cell | CUTLL1 |
Coordinate | chr2:61094170-61095580 |
SNPs | | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| LMX1B | MA0703.2 | chr2:61094846-61094857 | AATTTAATTAA | + | 6.32 | | Lhx3 | MA0135.1 | chr2:61094837-61094850 | AAATTAATTAATT | + | 6.92 | | Lhx3 | MA0135.1 | chr2:61094838-61094851 | AATTAATTAATTT | - | 6.92 | | PHOX2A | MA0713.1 | chr2:61094845-61094856 | TAATTTAATTA | + | 6.62 | | POU6F1 | MA0628.1 | chr2:61094839-61094849 | ATTAATTAAT | + | 6.02 | | POU6F1 | MA0628.1 | chr2:61094839-61094849 | ATTAATTAAT | - | 6.02 | | PROP1 | MA0715.1 | chr2:61094845-61094856 | TAATTTAATTA | - | 6.32 | | PROP1 | MA0715.1 | chr2:61094845-61094856 | TAATTTAATTA | + | 6.62 | | Phox2b | MA0681.1 | chr2:61094845-61094856 | TAATTTAATTA | + | 6.62 |
|
| | Number of super-enhancer constituents: 12 | ID | Coordinate | Tissue/cell |
| SE_10310 | chr2:61093433-61095949 | CD19_Primary | | SE_11106 | chr2:61092845-61096570 | CD20 | | SE_12280 | chr2:61094681-61095570 | CD3 | | SE_18697 | chr2:61094344-61095743 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_19449 | chr2:61094749-61095539 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_20318 | chr2:61094074-61095919 | CD56 | | SE_22541 | chr2:61094252-61095745 | CD8_primiary | | SE_59272 | chr2:61094485-61127769 | Ly3 | | SE_60183 | chr2:61088197-61118476 | Ly4 | | SE_60663 | chr2:61093350-61118259 | DHL6 | | SE_61297 | chr2:61094395-61128321 | HBL1 | | SE_62637 | chr2:61093736-61127689 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr2 | 61095047 | 61095409 | | chr2 | 61095090 | 61095322 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I060867 | chr2 | 61094192 | 61095934 |
|
Enhancer Sequence | TCACCTCATC TACTGTTCTG GTTATCTATT GCTGCATTAA CAATCCACCC CAAAGCTTAC 60
TGGCTTAAAA CAACAACAAT CATTTTATTA TCTCATGGTT TCTGTGGGTC AGGAATTCAG 120
GAAGAGCTCC ACTGAGTGGT TCTGGCTTAA TGTCTTACAT GCAGTGGCAG GAGATGGAAG 180
AGCAGGCATT GGGAGAGCTT GGGATGTCAG GGCCTCTCCA TGTGATCTGT TTACACGAAT 240
TAGTTTGTGC TTCCTCGCAG CATGATGGTC TCAGGGTAGT AATGCTTCTT AGATAGTGGC 300
TCAAGGCTCT AATGCAGGGT CCAGAGAACC AGGGAGAATC TGCACCACCT TTTTTGACTG 360
AGTCCGGAAG GTCACAGAGA ATCATTTCTG CCATACCCTA CTGGTCAACT AGTCACTAAT 420
GTTTGGCCCA AATTCAAAGG GAGGGCCACA AAGTTCACCT CATCATGGGG GGGAGATCAA 480
GGAATTTGCA GGTATGTTTT AAAACTGAAA CTAGCTGGGC CTGGTGGTGT GCACCTAATG 540
TGGTCCCAGC TGCTTGGTGG GCTAAGGTGG GAGGACTGCT TGAGCCTGGA AGATGGAGGC 600
TGCAGTGAGC GGTGATTGTA CCACTGCTCT CCTGCCTGGA GATAGAGCAA TACCCTGCCT 660
TGAAAATAAA TTAATTAATT TAATTAAATA ATGTTTTAAA ACTGCTACAA GCTGTGCAGA 720
AACATTCTTT GGTTTACGCA ATAATTACTC TGGCAAGAGA CATTTCTGTC TTCCTTTTAC 780
TTCCTTGTTT TCCTTCTCTT TCTTCTTTAA ATGATCCCCT TTAAGTGTTT ACAAATTTAA 840
AGATTTCAGC TCTAAATATT TTGTTTGTTT TATATATGTT CTGTATATAG ACCAATTCTT 900
GTGCCAGGCC CAAATATTTC CGGCTGCTCT GTTCTGCTCT GCCTACTTCC TGTTTGGTTG 960
ACTTTGACTT CCTGTCCTCT GTCAAAGGGC TTCATTAAAG TTATAAACTT CCATTTTGAC 1020
CTAGGCACTG TGTTCTATTT CTGAATCCGC CAGTGGTCTT GAGCAACAGT ACGCGTACGG 1080
TAACTGTTAA GTATAATACA GGAAGTGAAA ATTAAAGTAC TATGTCTTAA GATTGATAGA 1140
ATTAAATGCT CAGTTTAAGG AAATACATGG TGGAGACCAT TTTTCAGGAG CTCAGACCTC 1200
AGCCAGACTG AGTCTCTCTT TTAGGGATAG TTGGATCTCT CTTATTTTCG GCTGCAAATA 1260
ACAGGAAACT CAACTGGTTT ACATCATAAT GGAATATTTA TTATCTCATA TAACGAGGAG 1320
TCTGAGGTAG GATGGTTCCA ATTCAGCAGC TAATCATGTC ACCAAAAACT CAGATTCCTT 1380
CCAATTCTTT CTACTCTAAC ATCTTCAGTA 1410
|
